Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
cetyl tranexamate mesylate
- Development stage
- Unknown
- Lead developer
- Integrative Skin Science and Research
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Cetyl tranexamate mesylate is a lipophilic ester derivative of tranexamic acid designed to enhance skin penetration and efficacy for topical dermatological applications. It functions by inhibiting the plasminogen/plasmin pathway, which reduces the release of inflammatory mediators such as prostaglandins and arachidonic acid that stimulate melanogenesis. This mechanism makes it effective for treating various forms of hyperpigmentation, including melasma and acne-related post-inflammatory hyperpigmentation (PIH). It is frequently utilized in advanced cosmeceutical formulations, often paired with specialized delivery systems like TXVector to enhance its stability and bioavailability within the skin layers.
- Brand names
- TeraCeutic TXVector
- Other names
- cetyl tranexamatecetyl tranexamate salt
02
Targets
PLG (Plasminogen)
Beyond the preview
Go deeper on cetyl tranexamate mesylate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on cetyl tranexamate mesylate.